Physician profile
Stuart W Hough
NPI 1568417871
$3,104.35
in general payments reported to CMS, 2019-2025
13 companies · $1,356 in 2025
The $1,356 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $137 · 2022: $576 · 2023: $196 · 2024: $671 · 2025: $1,356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,330 · Travel and Lodging: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,330.33 |
| Travel and Lodging | $892.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $1,120.56 | 2025 | Iovera |
| Relievant Medsystems, INC. | $539.67 | 2022-2023 | Intracept |
| Nevro Corp. | $328.75 | 2020-2024 | Senza |
| Saluda Medical Americas, INC. | $327.76 | 2024 | Evoke |
| Vertos Medical, INC. | $227.90 | 2019-2024 | Mild Device Kit |
| Globus Medical, INC. | $157.68 | 2025 | Senza |
| Boston Scientific Corporation | $122.22 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Medtronic USA, INC. | $120.78 | 2019-2020 | |
| Medtronic, INC. | $88.91 | 2023-2025 | Kyphon Express II Kyphopak Tray, Vanta Adaptivestim, Inceptiv |
| Collegium Pharmaceutical, INC. | $28.43 | 2025 | Belbuca |
| Abbott Laboratories | $20.44 | 2023 | Proclaim |
| Ambu INC. | $17.45 | 2022 | |
| Mml US, INC. | $3.80 | 2023 | Reactiv8 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Hough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.